STOCK TITAN

22Nd Century Stock Price, News & Analysis

XXII Nasdaq

Welcome to our dedicated page for 22Nd Century news (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22Nd Century stock.

News for 22nd Century Group, Inc. (Nasdaq: XXII) centers on its role in tobacco harm reduction, regulatory developments, capital structure actions and the commercialization of its VLN® reduced nicotine cigarette platform. Company announcements frequently highlight progress in expanding VLN® and partner VLN® distribution across additional U.S. states and retail chains, including launches with major convenience store operators and authorizations in a large majority of states.

Investors following XXII news will see updates on VLN® regulatory milestones, such as the original FDA Modified Risk Tobacco Product authorization, the filing of the VLN® MRTP renewal application, and the company’s public support for the FDA’s proposed Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products. Releases also discuss clinical research findings related to very low nicotine content cigarettes, including reductions in daily cigarette consumption and increased quit attempts among smokers using 95% reduced nicotine VLN® products.

Another recurring theme in 22nd Century’s news is financial and corporate developments. The company reports on balance sheet changes such as repayment and termination of senior secured debt, settlement of insurance claims related to prior facility incidents, and the use of non-dilutive cash proceeds as growth capital. News items also cover equity and preferred stock financings, at-the-market offering arrangements, and proposals for reverse stock splits and other shareholder approvals under Nasdaq Listing Rules.

In addition, XXII news includes corporate governance and investor relations events, such as participation in investor conferences, quarterly earnings webcasts, and shareholder letters reviewing strategic progress. For readers tracking the intersection of tobacco regulation, reduced nicotine technology and public company capital markets activity, the XXII news feed provides ongoing context on how 22nd Century is executing its harm reduction-focused strategy.

Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) announced the initial shipments of its Pinnacle VLN® Gold and Pinnacle VLN® Menthol reduced nicotine cigarettes. The products will launch on September 1, 2025 across nearly 1,000 locations in 12 states through a top-5 U.S. convenience store chain.

The Pinnacle VLN® cigarettes contain 95% less nicotine compared to traditional cigarettes, meeting the FDA's proposed standard of less than 0.7 mg/g nicotine content. These products are the first and only FDA-authorized combusted cigarettes specifically designed to reduce nicotine intake, supported by extensive clinical research demonstrating their effectiveness in reducing smoking habits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
none
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) welcomes the American Academy of Family Physicians' (AAFP) support for the FDA's proposed reduced nicotine mandate. The AAFP, representing over 128,300 family physicians, endorses establishing a maximum nicotine yield of 0.7 milligrams per gram of tobacco in combustible products.

The company's VLN® products, including partner brands Smoker Friendly VLN® and Pinnacle VLN®, are currently the only FDA-authorized reduced nicotine content cigarettes that comply with the proposed standard. According to the release, smoking causes over 480,000 deaths and costs more than $600 billion annually in the United States, while reducing life expectancy by 10 years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.61%
Tags
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) announced significant progress in state authorizations for its tobacco product portfolio. The company has secured approval to sell its VLN® reduced nicotine content cigarettes in up to 41 states, along with expanded authorizations for partner brands and conventional products.

The company's flagship VLN® products contain 95% less nicotine than conventional cigarettes and are the only combustible cigarettes that comply with the FDA's proposed Low Nicotine Mandate. 22nd Century has secured partnerships with retailers representing over 2,000 outlets for implementation in the second half of 2025.

The expanded state authorizations cover multiple product lines including VLN® Gold and Green (41 states), VLN® Red (21 states), Smoker Friendly VLN® (20 states), Pinnacle® VLN® (20 states), and various conventional products across different states.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.2%
Tags
none
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) is gaining traction with its VLN® reduced nicotine content cigarettes as multiple tobacco brands partner to expand product availability. The company's proprietary tobacco contains 95% less nicotine than conventional cigarettes, meeting the FDA's proposed standard of 0.7 mg nicotine per gram of tobacco.

The FDA's January 2025 proposed Tobacco Product Standard aims to reduce smoking-related harm by limiting nicotine content in cigarettes. VLN® products, averaging 0.5 mg per gram, are currently the only FDA-authorized combustible cigarettes meeting this standard. The FDA projects this initiative could prevent approximately 48 million youth and young adults from starting smoking by 2100.

New partnerships including Smoker Friendly VLN® and Pinnacle VLN® demonstrate growing industry adoption ahead of the standard's implementation, expected two years after final approval.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.99%
Tags
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) provided an update on the Modified Risk Tobacco Product (MRTP) renewal process for its VLN® reduced nicotine content products. VLN® is the first and only FDA-authorized combustible cigarette containing 95% less nicotine than conventional cigarettes, with renewal due in December 2026.

The company's VLN® products, originally authorized in December 2021, have demonstrated through extensive clinical research their ability to reduce smoking rates, increase quit attempts, and lower nicotine consumption. The product line is expanding with more brands using VLN® tobacco, meeting FDA's proposed low nicotine mandate issued in January 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.11%
Tags
-
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) has announced "Operation 100," an initiative to develop a 100mm version of their VLN® reduced nicotine content cigarettes. The company plans to submit this new product for FDA approval in Q4 2025.

The 100mm format targets approximately half of the U.S. smoking market and will complement their existing FDA-authorized 84mm king size VLN® cigarettes. The product will be available under the VLN® brand and through partner brands like Smoker Friendly and Pinnacle.

Clinical studies have demonstrated that 22nd Century's proprietary reduced nicotine tobacco helps lower cigarette consumption, increases quit attempts, and reduces cigarette dependence without compensatory smoking behaviors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.75%
Tags
none
Rhea-AI Summary

22nd Century Group (Nasdaq: XXII) has expanded its Pinnacle brand partnership with a top-5 convenience store chain, launching four new products including two VLN® (low nicotine) cigarette variants and two moist snuff products. The products will be distributed across more than 1,700 stores in 27 states.

The new products include Pinnacle VLN® Gold cigarettes, Pinnacle Menthol VLN® cigarettes, and straight and wintergreen flavored moist snuff. Sales are expected to begin in late summer and early fall 2025, pending state approvals. The agreement also includes potential expansion to other retail and c-store chains.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.6%
Tags
none
-
Rhea-AI Summary

22nd Century Group (NASDAQ: XXII), a tobacco products company focused on nicotine control solutions, has announced that CEO Larry Firestone will deliver a corporate update presentation at the Emerging Growth Conference on May 21, 2025, at 12:00 PM ET. The presentation will cover recent company developments and include a potential Q&A session.

Investors can submit questions in advance via email and register for the event through the provided webcast link. For those unable to attend live, an archived recording will be available on EmergingGrowth.com and the Emerging Growth YouTube Channel.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.45%
Tags
conferences
-
Rhea-AI Summary
22nd Century Group (XXII) reported Q1 2025 financial results showing sequential growth but continued losses. Net revenues increased 50% to $6.0M from Q4 2024's $4.0M, driven by increased cigarette volumes. However, the company posted a gross loss of $0.6M and a net loss of $3.3M, though improved from Q4 2024's $4.2M loss. Operating expenses decreased to $2.0M, the lowest since 2023's restructuring. Key developments include new VLN® branding, launch of VLN® Red product, and regulatory filings in all 50 states. The company is preparing to ship its first VLN® partner brand products and has begun shipments under a new five-year agreement with Smoker Friendly. Cigarette volumes increased to 319,000 cartons from 228,000 in Q4 2024. The company ended Q1 with net debt of $3.4M, subsequently reducing total debt to $3.9M post-quarter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.48%
Tags
Rhea-AI Summary

22nd Century Group (NASDAQ: XXII) has completed the sale of its Needle Rock Farms assets for net proceeds of approximately $770,000 after expenses. The assets were previously related to the company's hemp cannabis business, which was divested in December 2023. CEO Larry Firestone stated that the proceeds will strengthen the company's cash position and support their 2025 revenue growth strategies, including new VLN® and Partner VLN® launches. The company will report its Q1 2025 results on May 13, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16%
Tags
none

FAQ

What is the current stock price of 22Nd Century (XXII)?

The current stock price of 22Nd Century (XXII) is $1.98 as of April 17, 2026.

What is the market cap of 22Nd Century (XXII)?

The market cap of 22Nd Century (XXII) is approximately 1.5M.